|
XPC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.894240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.672400E-01 |
| Normal-vs-Stage2 |
8.967400E-01 |
| Normal-vs-Stage3 |
1.687560E-01 |
| Normal-vs-Stage4 |
9.155700E-03 |
| Stage1-vs-Stage2 |
6.540800E-01 |
| Stage1-vs-Stage3 |
8.696400E-02 |
| Stage1-vs-Stage4 |
2.410100E-02 |
| Stage2-vs-Stage3 |
4.058000E-01 |
| Stage2-vs-Stage4 |
9.498200E-02 |
| Stage3-vs-Stage4 |
2.978200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.199150E-01 |
| Normal-vs-AfricanAmerican |
3.826000E-01 |
| Normal-vs-Asian |
5.868000E-01 |
| Caucasian-vs-AfricanAmerican |
7.921800E-02 |
| Caucasian-vs-Asian |
4.017600E-01 |
| AfricanAmerican-vs-Asian |
8.073800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.631800E-01 |
| Normal-vs-Female |
3.214200E-01 |
| Male-vs-Female |
8.110200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.481200E-01 |
| Normal-vs-Extreme_Weight |
6.218600E-01 |
| Normal-vs-Obese |
3.725400E-01 |
| Normal-vs-Extreme_Obese |
7.491200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.084600E-01 |
| Normal_Weight-vs-Obese |
1.252550E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.816800E-01 |
| Extreme_Weight-vs-Obese |
7.049400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.927800E-01 |
| Obese-vs-Extreme_Obese |
9.536600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.210400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.290800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.147400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.087600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.174600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.953400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.496800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.543600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.964200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.915400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.817300E-04 |
| Normal-VS-Type2 PRCC |
1.438450E-04 |
| Normal-VS-KIRP CIMP |
3.131400E-01 |
| Normal-VS-Unclassified PRCC |
7.232300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.17940004826534E-09 |
| Type1 PRCC-VS-KIRP CIMP |
7.729500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.871400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.569000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.831400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
3.560000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.405220E-01 |
| Normal-vs-N1 |
9.644200E-02 |
| Normal-vs-N2 |
2.07949999997403E-06 |
| N0-vs-N1 |
6.853800E-01 |
| N0-vs-N2 |
1.035040E-01 |
| N1-vs-N2 |
1.140840E-01 |
|
|
